Experiment 1141203
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | KOELLER,JM: TRUMP,DL: WITTE,RS: DAVIS,TE: NELSON,RL: TORMEY,DC: RAMIREZ,G:. (1984). PHASE I TRIAL AND PHARMACOKINETICS OF VINZOLIDINE ON A DAILY X 5 ORAL SCHEDULE.. 1984() |
| Amount utilized | |
| Compound isolated | |
| Disease | IN THIS PHASE I TRIAL 20 PATIENTS WERE TREATED DAYS 1-5, EVERY 28 DAYS WITH 60% OF THE DOSE ON DAY 1 AND 10% ON DAYS 2-5. THE DOSE-LIMITING TOXICITY WAS MYELOSUPPRESION. THERE WERE 2 PARTIAL RESPONSES OF 20 AND 30 WEEKS. |
| Dose amount | 30.60 MG |
| Number | 1 |
| Qualitative result | EQUIVOCAL |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |